Impaired kidney function Withdrawn Phase 2 Trials for Simeprevir (DB06290)

Also known as: Kidney impairment / Renal Impairment / Renal Impairments / Renal Insufficiency / Impaired Renal Function / Insufficiency renal / Renal impairment NOS / Kidney Failure / Renal failure / Failure kidney / Uremia NOS / Renal failure, unspecified / Renal failure NOS / Renal failure unspecified

IndicationStatusPhase
DBCOND0098871 (Impaired kidney function)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02397395An Efficacy, Safety, Tolerability and Pharmacokinetics Study of 12 Weeks Treatment With Simeprevir and Daclatasvir in Participants With Chronic Hepatitis C Virus Genotype 1b or 4 Infection and Either Severe Renal Impairment or End-stage Renal Disease on Hemodialysis.Treatment